Pfizer Q3CY1 Result Update; Downgrade earnings estimates; Maintain Hold; Target Price: Rs 1,100

Pfizer Ltd

Reco: Hold

CMP: Rs1,093

Target Price: Rs1,100

Downgrade earnings estimates; Maintain Hold

·      Pfizers Q3CY10 performance was disappointing except on sales front with a) Revenue of Rs2.4bn (in-line), b) EBIDTA of Rs523mn (est. Rs557bn) and c) APAT of Rs435mn (est. Rs478mn)

·      Lower other income, higher employee cost and one time professional fees impacted operating profitability

·      Tweak earnings by 5% each for CY10/11E. Maintain Hold

 

--
Safe Harbor:
The information contained and provided on this Website provides Investment advice for the education of investors. The posts are an information service only. Recommendations, opinions or suggestions are given with the understanding that readers acting on this information assume all risks involved. We do not assume any responsibility or liability resulting from the use of such information, judgment and opinions for Trading or Investment purposes.
 
You received this message because you are subscribed to the Google Groups "Investors Please Listen !" group.
To post to this group, send email to investorspleaselisten@googlegroups.com
To unsubscribe from this group, send email to
investorspleaselisten+unsubscribe@googlegroups.com For more options, visit this group at http://groups.google.com/group/investorspleaselisten?hl=en